Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,123 INR | +6.77% | +13.93% | +62.61% |
May. 20 | Jefferies Adjusts Zydus Lifesciences' Price Target to INR1,070 From INR750, Keeps at Hold | MT |
May. 17 | Transcript : Zydus Lifesciences Limited, Q4 2024 Earnings Call, May 17, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+62.61% | 13.34B | |
+21.64% | 44.12B | |
+23.03% | 22.61B | |
+18.22% | 15.11B | |
+13.66% | 13.61B | |
-8.80% | 6.94B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+15.65% | 5.75B | |
+6.11% | 4.78B |
- Stock Market
- Equities
- ZYDUSLIFE Stock
- News Zydus Lifesciences Limited
- Zydus Lifesciences Gets US FDA Final Approval for Generic Chest Pain Drug